Trial Profile
Efficacy of palbociclib with or without trastuzumabin patients with Rb+ advanced breast cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 22 Feb 2017
Price :
$35
*
At a glance
- Drugs Palbociclib (Primary) ; Trastuzumab
- Indications Advanced breast cancer
- Focus Adverse reactions; Therapeutic Use
- 22 Feb 2017 New trial record
- 12 May 2014 Protocol has amended to allow the concomitant administration of trasruzumab